Providing an overview of antipsychotic drugs: Is schizophrenia a psychiatric challenge? Is schizophrenia a psychiatric challenge?

Natalie Schellack*, Moliehi Matlala

*Corresponding author for this work

Research output: Contribution to journalLiterature reviewpeer-review

Abstract

"Psychosis" is an umbrella term used in the description of various conditions that involve delusions and hallucinations. This article will focus on the management of schizophrenia. Schizophrenia is a complex disorder, which provides many pharmacotherapy-related challenges. Advances have been made in the treatment of the condition. However, this requires a team approach, with the pharmacist monitoring treatment, both for safety and efficacy. The involvement of medicines that might possibly modulate the N-methyl-D-aspartate receptors is an exciting development that should be monitored. © Medpharm.
Original languageEnglish
Pages (from-to)28-33
Number of pages6
JournalSA Pharmaceutical Journal
Volume81
Issue number4
Publication statusPublished - 1 Jan 2014

Keywords

  • Antipsychotic drugs
  • First-generation antipsychotic drugs
  • Schizophrenia
  • Second-generation antipsychotic drugs

Fingerprint

Dive into the research topics of 'Providing an overview of antipsychotic drugs: Is schizophrenia a psychiatric challenge? Is schizophrenia a psychiatric challenge?'. Together they form a unique fingerprint.

Cite this